SpringTide Ventures is on record against 10 companies.
The firm invests at Seed through Series A, focusing exclusively on health-tech. They target underserved patient populations, leveraging embedded clinical operators and a network of policymakers. Their geographic focus is implicit but likely North America, given their policy access.